Stockreport

Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan [Yahoo! Finance]

Serina Therapeutics, Inc.  (SER) 
PDF American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, today reported that the NYSE American LLC [Read more]